In this trial, where we are evaluating the safety and tolerability of an experimental new drug, an injection is being developed as a prophylactic against tetanus. This injection is a human monoclonal antibody against tetanus toxin. Monoclonal antibodies are a type of protein or antibody that is produced by a single clone of cells, these antibodies or proteins will only bind to one substance or foreign body. The study drug or a placebo will be administered as an intramuscular (into the muscle) injection.
If you meet the criteria for this study and would like more information, register below or call 1800 727 874.